Literature DB >> 19251575

Tocilizumab-induced erythroderma.

Motonobu Nakamura, Yoshiki Tokura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19251575     DOI： 10.1684/ejd.2009.0642

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  3 in total

Review 1.  Adverse reactions to biologic agents and their medical management.

Authors:  Onur Boyman; Denis Comte; François Spertini
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

2.  'Toxic erythema' and eosinophilia associated with tocilizumab therapy in a COVID-19 patient.

Authors:  A Sernicola; G Carnicelli; M Di Fraia; C Chello; C Furlan; R Muharremi; G Paolino; T Grieco
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-08       Impact factor: 9.228

3.  Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper.

Authors:  Aslı Gelincik; Knut Brockow; Gülfem E Çelik; Inmaculada Doña; Cristobalina Mayorga; Antonino Romano; Özge Soyer; Marina Atanaskovic-Markovic; Annick Barbaud; Maria Jose Torres
Journal:  Allergy       Date:  2020-07-01       Impact factor: 14.710
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.